Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.

Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.

Contact SupportLog In

astrazeneca cover image

Posted in: SGLT2i Aug 29 | 2019DAPA-HF @ ESC 2019 on Sunday Sept 1 Purchase Blast

astrazeneca cover image

Posted in: SGLT2i Aug 27 | 2019AZ's Farxiga CKD Development Receives Fast Track Designation Purchase Blast

Posted in: SGLT2i Aug 26 | 2019Invokana CREDENCE Filing Accepted by EMA; Dexcom Wins Patent Dispute with AgaMatrix Purchase Blast

adocia and lilly cover image

Posted in: Basal Insulin, Bolus Insulin Aug 23 | 2019Lilly Wins in Arbitration with Adocia Purchase Blast

astrazeneca cover image

Posted in: SGLT2i Aug 22 | 2019Thoughts on AZ PRV Purchase and Potential Uses Purchase Blast

Posted in: Basal Insulin Aug 22 | 2019Biocon’s Glargine Facility Receives EU GMP Certification Purchase Blast

novo cover image

Posted in: GLP-1RA Aug 21 | 2019Novo Sues Mylan Over Generic Victoza Purchase Blast

astrazeneca cover image

Posted in: SGLT2i Aug 20 | 2019Farxiga Positive Topline DAPA-HF Results Purchase Blast

medtronic cover image

Posted in: Glucose Monitoring, Insulin Delivery Aug 20 | 2019Medtronic CY Q2 '19 (FY Q1 '20) Earnings Update Purchase Blast

medtronic cover image

Posted in: Insulin Delivery Aug 16 | 2019Medtronic Extended Wear Infusion Set Purchase Blast

novo cover image

Posted in: Other Aug 16 | 2019New Novo Nordisk Ph1 Compound With Unknown MOA Purchase Blast

zealand cover image

Posted in: Dual/triple agonist, Glucagon, Other Aug 15 | 2019Zealand to Launch HypoPal in the US Without a Partner; Zealand Q2 '19 Earnings Update Purchase Blast

novo cover image

Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other Aug 12 | 2019Novo: Updated FENIX Viewpoint; Novo Q2 '19 London Earnings Update Purchase Blast

lilly cover image

Posted in: Dual/triple agonist Aug 09 | 2019Two New Lilly Ph1 Tirzepatide Trials Purchase Blast

novo cover image

Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal Aug 09 | 2019Novo: REDUCE-IT Adcom Readthrough to Oral Sema? MYL Generic Victoza Filed; Q2 '19 Earnings Update Purchase Blast

Posted in: Bolus Insulin, Glucose Monitoring Aug 07 | 2019MannKind and Senseonics Q2 '19 Earnings Updates Purchase Blast

xeris cover image

Posted in: Glucagon Aug 07 | 2019Xeris Q2 ’19 Earnings Update Purchase Blast

BD cover image

Posted in: Insulin Delivery Aug 06 | 2019BD Swatch pump 510(k) withdrawn; BD CY Q2 ’19 (FY Q3 ’19) Earnings Update Purchase Blast

insulet cover image

Posted in: Insulin Delivery Aug 05 | 2019Insulet Q2 '19 Earnings Update Purchase Blast

Posted in: Bolus Insulin, Insulin Delivery, Other, SGLT2i Aug 05 | 2019Forxiga DECLARE EU Approval, BTD For Provention Bio's Teplizumab (PRV-031), And MannKind/One Drop Collaboration Purchase Blast

« prev 1 … 68 69 70 71 72 … 95 next »